1.Gemcitabine plus S-1 versus gemcitabine alone in the treatment of advanced pancreatic cancer: a Meta-analysis
Journal of International Oncology 2014;41(3):233-237
Objective To compare the gemcitabine (GEM) plus S-1 and gemcitabine alone in the treatment of advanced pancreatic cancer (PC) by meta-analysis.Methods Articles were searched in PubMed,Cochrane library,Embase,CNKI,and CBM up to August 1st,2013.Only randomized controlled trails (RCTs) for GEM + S-1 and GEM alone in advanced PC were included.Two reviewers retrieved and collected data respectively.Data were selected basing on inclusion and exclusion criteria.The meta-analysis was base on survival advantage (include overall survival and progress free survival),object response rate,disease control rate and adverse reaction.Results A total of 3 trials with 772 cases were included.Meta-analysis demonstrated that GEM plus S-1 significantly improved the progress free survival (HR:0.64,95%CI:0.54-0.75,P < 0.000 01) and overall survival (HR:0.81,95%CI:0.68-0.96,P =0.01),improved object response rate (RD:0.16,95% CI:0.10-0.21,P < 0.000 01) and disease control rate (RD:0.10,95% CI:0.03-0.17,P =0.009) also.However,the incidence of WHO 3/4 grade adverse reaction was increased significantly in the GEM + S-1 group.Neutropenia,thrombocytopenia,and gastrointestinal reaction were increased by 18% (P =0.02),18% (P =0.008) and 8% (P < 0.000 01)respectively.Conclusion GEM combined with S-1 can improve the chemotherapy effect compared with GEM alone.The adverse reactions also increase significantly,but the overall survival is benefit.
2.Ectopic Over-expression of Oncogene Pim-2 Induce Malignant Transformation of Nontumorous Human Liver Cell Line L02.
Ke REN ; Wentao DUAN ; Yujun SHI ; Bo LI ; Zuojin LIU ; Jiangping GONG
Journal of Korean Medical Science 2010;25(7):1017-1023
In order to prove that ectopic over-expression of Pim-2 could induce malignant transformation of human liver cell line L02, three groups of cells were set up including human liver cell line L02 (L02), L02 cells transfected with Pim-2 gene (L02/Pim-2) and L02 cells transfected with empty-vector (L02/Vector). Pim-2 expression levels were detected. The morphology, proliferation level, apoptosis rate and migration ability of the cells were detected respectively. Then the cells were subcutaneously inoculated into athymic mice and the microstructures of the neoplasm were observed. Compared with the controls, Pim-2 expression levels were significantly higher in L02/Pim-2 cells (P<0.05), and their morphology had obvious malignant changes. They also showed a significantly increased proliferation rate (P<0.05) and migration capacity (P<0.05), as well as a significantly decreased apoptosis rate (P<0.05). Only the athymic mice inoculated with L02/Pim-2 cells could generate neoplasm, and the morphology of the neoplasm coincided with that of the hepatoma. The results manifest that ectopic Pim-2 gene could be stably expressed in L02/Pim-2 cells. Both the morphological and biological changes of L02/Pim-2 cells demonstrate the trend of malignant transformation. L02/Pim-2 cells could generate hepatoma in athymic mice. In conclusion, Pim-2 could induce malignant transformation of human liver cell line L02.
Animals
;
Apoptosis
;
Cell Line
;
Cell Movement
;
Cell Proliferation
;
*Cell Transformation, Neoplastic
;
Humans
;
Liver/pathology/physiology
;
*Liver Neoplasms/genetics/pathology
;
Mice
;
Mice, Nude
;
Neoplasm Transplantation
;
*Oncogenes
;
Protein-Serine-Threonine Kinases/genetics/*metabolism
;
Proto-Oncogene Proteins/genetics/*metabolism